$199.75
-8.79-4.22%
al cierre: -
$200.76
1.010.51%
After hour: Nov 14, 7:59 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Strategy Inc tiene un precio objetivo de consenso de $515.12 basado en las calificaciones de 18 analistas. El máximo es $705, emitido por Benchmark el agosto 1, 2025. El mínimo es $54, emitido por Wells Fargo el septiembre 30, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por HC Wainwright & Co., Canaccord Genuity y TD Cowen el noviembre 3, 2025, noviembre 3, 2025 y octubre 31, 2025, respectivamente. Con un precio objetivo promedio de $494.67 entre HC Wainwright & Co., Canaccord Genuity y TD Cowen, hay una 146.40% upside implícita para Strategy Inc según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
HC Wainwright & Co.
Canaccord Genuity
TD Cowen
Cantor Fitzgerald
BTIG
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Strategy
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/10/2025 | — | Monness, Crespi, Hardt | — | Upgrade | Sell → Neutral | |||
11/03/2025 | 136.6% | HC Wainwright & Co. | $521 → $475 | Maintains | Buy | |||
11/03/2025 | 136.1% | Canaccord Genuity | $464 → $474 | Maintains | Buy | |||
10/31/2025 | 166.49% | TD Cowen | $620 → $535 | Maintains | Buy | |||
10/31/2025 | 178.94% | Cantor Fitzgerald | $697 → $560 | Maintains | Overweight | |||
10/31/2025 | 213.81% | BTIG | $700 → $630 | Maintains | Buy | |||
10/21/2025 | 141.58% | Citigroup | → $485 | Initiates | → Buy | |||
10/15/2025 | 135.6% | China Renaissance | → $473 | Initiates | → Buy | |||
09/30/2025 | -73.1% | Wells Fargo | $65 → $54 | Downgrade | Overweight → Equal-Weight | |||
09/16/2025 | 208.83% | TD Cowen | $640 → $620 | Maintains | Buy | |||
08/26/2025 | 131.12% | Canaccord Genuity | $464 → $464 | Maintains | Buy | |||
08/11/2025 | 191.89% | Mizuho | $563 → $586 | Maintains | Outperform | |||
08/01/2025 | 248.68% | BTIG | $620 → $700 | Maintains | Buy | |||
08/01/2025 | 251.17% | Benchmark | $650 → $705 | Maintains | Buy | |||
08/01/2025 | 247.18% | Cantor Fitzgerald | $680 → $697 | Maintains | Overweight | |||
07/28/2025 | 238.71% | Cantor Fitzgerald | $614 → $680 | Maintains | Overweight | |||
07/15/2025 | 238.71% | TD Cowen | $590 → $680 | Maintains | Buy | |||
05/05/2025 | 136.6% | Barclays | $421 → $475 | Maintains | Overweight | |||
05/05/2025 | 205.84% | Cantor Fitzgerald | $619 → $614 | Maintains | Overweight | |||
05/02/2025 | 159.51% | HC Wainwright & Co. | $480 → $521 | Maintains | Buy | |||
05/02/2025 | 131.12% | Canaccord Genuity | $409 → $464 | Maintains | Buy | |||
04/29/2025 | 139.09% | HC Wainwright & Co. | → $480 | Initiates | → Buy | |||
02/10/2025 | 109.7% | Barclays | $515 → $421 | Maintains | Overweight | |||
02/07/2025 | 178.94% | Keefe, Bruyette & Woods | → $560 | Initiates | → Outperform | |||
02/06/2025 | 149.05% | Maxim Group | $480 → $500 | Maintains | Buy | |||
02/06/2025 | 208.33% | Cantor Fitzgerald | $613 → $619 | Maintains | Overweight | |||
02/06/2025 | 103.73% | Canaccord Genuity | $510 → $409 | Maintains | Buy | |||
01/29/2025 | 156.53% | Mizuho | → $515 | Initiates | → Outperform | |||
01/14/2025 | 223.77% | Benchmark | $650 → $650 | Reiterates | Buy → Buy | |||
01/06/2025 | 223.77% | Benchmark | $650 → $650 | Reiterates | Buy → Buy | |||
12/12/2024 | 198.86% | Bernstein | $600 → $600 | Reiterates | Outperform → Outperform | |||
11/25/2024 | 161.51% | TD Cowen | — | $392 → $525 | Maintains | Buy | ||
11/25/2024 | 156.53% | Barclays | $275 → $515 | Maintains | Overweight | |||
11/25/2024 | 223.77% | Benchmark | $450 → $650 | Maintains | Buy | |||
11/25/2024 | 198.86% | Bernstein | $290 → $600 | Maintains | Outperform | |||
11/25/2024 | 154.03% | Canaccord Genuity | $300 → $510 | Maintains | Buy | |||
11/21/2024 | 183.92% | BTIG | $290 → $570 | Maintains | Buy | |||
11/19/2024 | 124.15% | Benchmark | $300 → $450 | Maintains | Buy | |||
11/04/2024 | 36.98% | Barclays | $225 → $275 | Maintains | Overweight | |||
10/31/2024 | 49.43% | Canaccord Genuity | $173 → $300 | Maintains | Buy | |||
10/31/2024 | 34.49% | Maxim Group | $193 → $270 | Maintains | Buy | |||
10/31/2024 | 49.43% | TD Cowen | $200 → $300 | Maintains | Buy | |||
10/31/2024 | 49.43% | Benchmark | $245 → $300 | Maintains | Buy | |||
10/21/2024 | 19.55% | BTIG | $180 → $240 | Maintains | Buy | |||
10/18/2024 | 22.04% | Benchmark | $215 → $245 | Maintains | Buy | |||
10/14/2024 | 12.07% | Barclays | $173 → $225 | Maintains | Overweight | |||
10/09/2024 | 44.45% | Bernstein | $2890 → $290 | Maintains | Outperform | |||
09/23/2024 | -13.83% | Barclays | $146 → $173 | Maintains | Overweight | |||
09/23/2024 | -0.38% | TD Cowen | $195 → $200 | Maintains | Buy | |||
09/16/2024 | -13.83% | Canaccord Genuity | $185 → $173 | Maintains | Buy | |||
09/06/2024 | -27.28% | Barclays | → $146 | Initiates | → Overweight | |||
08/21/2024 | -3.37% | Cantor Fitzgerald | → $194 | Initiates | → Overweight | |||
08/02/2024 | 861.35% | Maxim Group | $1835 → $1930 | Maintains | Buy | |||
08/02/2024 | 970.93% | Benchmark | $1875 → $2150 | Maintains | Buy | |||
06/25/2024 | 814.03% | Maxim Group | → $1835 | Initiates | → Buy | |||
06/24/2024 | 809.54% | Canaccord Genuity | $2047 → $1826 | Maintains | Buy | |||
06/21/2024 | 836.44% | TD Cowen | $1450 → $1880 | Maintains | Buy | |||
06/14/2024 | 1339.53% | Bernstein | → $2890 | Initiates | → Outperform | |||
06/13/2024 | 1339.53% | Bernstein | → $2890 | Initiates | → Outperform | |||
05/29/2024 | 919.63% | Canaccord Genuity | $1590 → $2047 | Maintains | Buy | |||
04/30/2024 | 833.95% | Benchmark | $1875 → $1875 | Reiterates | Buy → Buy | |||
04/30/2024 | 691.99% | Canaccord Genuity | $1810 → $1590 | Maintains | Buy | |||
04/25/2024 | 833.95% | Benchmark | $1875 → $1875 | Reiterates | Buy → Buy | |||
04/08/2024 | 833.95% | Benchmark | $990 → $1875 | Maintains | Buy | |||
04/05/2024 | 796.59% | BTIG | $780 → $1800 | Maintains | Buy | |||
03/28/2024 | 801.57% | Canaccord Genuity | → $1810 | Reiterates | Buy → Buy | |||
03/20/2024 | 622.26% | TD Cowen | $1560 → $1450 | Maintains | Outperform | |||
03/12/2024 | 677.05% | TD Cowen | $1220 → $1560 | Maintains | Outperform | |||
03/12/2024 | 801.57% | Canaccord Genuity | $975 → $1810 | Maintains | Buy | |||
12/28/2023 | 294% | Canaccord Genuity | $670 → $791 | Maintains | Buy | |||
12/11/2023 | 243.69% | BTIG | $560 → $690 | Maintains | Buy | |||
12/06/2023 | 233.73% | Canaccord Genuity | $554 → $670 | Maintains | Buy | |||
12/05/2023 | 233.73% | Canaccord Genuity | $554 → $670 | Maintains | Buy | |||
11/02/2023 | 175.95% | Canaccord Genuity | $513 → $554 | Maintains | Buy | |||
07/26/2023 | 159.02% | TD Cowen | → $520 | Initiates | → Outperform | |||
07/11/2023 | 144.07% | BTIG | → $490 | Assumes | → Buy | |||
04/28/2023 | 114.19% | Berenberg | → $430 | Initiates | → Buy | |||
02/03/2023 | 99.24% | Canaccord Genuity | $372 → $400 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Strategy (MSTR)?
El último precio objetivo de Strategy (NASDAQ:MSTR) fue comunicado por Monness, Crespi, Hardt el noviembre 10, 2025. La firma de analistas fijó un precio objetivo para $0.00 que espera MSTR a fall dentro de 12 meses (un posible -100.00% downside). 38 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Strategy (MSTR)?
La última calificación de analistas para Strategy (NASDAQ:MSTR) fue proporcionada por Monness, Crespi, Hardt, y Strategy mejorado su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Strategy (MSTR)?
La última revisión al alza de Strategy Inc se produjo en noviembre 10, 2025, cuando Monness, Crespi, Hardt elevó su precio objetivo a N/A. Monness, Crespi, Hardt anteriormente tenía a sell para Strategy Inc.
¿Cuándo fue la última revisión a la baja de Strategy (MSTR)?
La última revisión a la baja de Strategy Inc se produjo en septiembre 30, 2025, cuando Wells Fargo cambió su precio objetivo de $65 a $54 para Strategy Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Strategy (MSTR)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Strategy, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Strategy se registró el noviembre 10, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 10, 2026.
¿Es correcta la calificación de los analistas sobre Strategy (MSTR)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Strategy (MSTR) fue un mejorado con un precio objetivo de $0.00 a $0.00. El precio actual al que cotiza Strategy (MSTR) es de $200.76, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.